234 related articles for article (PubMed ID: 23149842)
1. An inherited NBN mutation is associated with poor prognosis prostate cancer.
Cybulski C; Wokołorczyk D; Kluźniak W; Jakubowska A; Górski B; Gronwald J; Huzarski T; Kashyap A; Byrski T; Dębniak T; Gołąb A; Gliniewicz B; Sikorski A; Switała J; Borkowski T; Borkowski A; Antczak A; Wojnar L; Przybyła J; Sosnowski M; Małkiewicz B; Zdrojowy R; Sikorska-Radek P; Matych J; Wilkosz J; Różański W; Kiś J; Bar K; Bryniarski P; Paradysz A; Jersak K; Niemirowicz J; Słupski P; Jarzemski P; Skrzypczyk M; Dobruch J; Domagała P; Narod SA; Lubiński J;
Br J Cancer; 2013 Feb; 108(2):461-8. PubMed ID: 23149842
[TBL] [Abstract][Full Text] [Related]
2. A personalised approach to prostate cancer screening based on genotyping of risk founder alleles.
Cybulski C; Wokołorczyk D; Kluźniak W; Kashyap A; Gołąb A; Słojewski M; Sikorski A; Puszyński M; Soczawa M; Borkowski T; Borkowski A; Antczak A; Przybyła J; Sosnowski M; Małkiewicz B; Zdrojowy R; Domagała P; Piotrowski K; Menkiszak J; Krzystolik K; Gronwald J; Jakubowska A; Górski B; Dębniak T; Masojć B; Huzarski T; Muir KR; Lophatananon A; Lubiński J; Narod SA;
Br J Cancer; 2013 Jun; 108(12):2601-9. PubMed ID: 23722471
[TBL] [Abstract][Full Text] [Related]
3. Inherited NBN Mutations and Prostate Cancer Risk and Survival.
Rusak B; Kluźniak W; Wokołorczykv D; Stempa K; Kashyap A; Gronwald J; Huzarski T; Dębniak T; Jakubowska A; Masojć B; Akbari MR; Narodv SA; Lubiński J; Cybulski C
Cancer Res Treat; 2019 Jul; 51(3):1180-1187. PubMed ID: 30590007
[TBL] [Abstract][Full Text] [Related]
4. Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population.
Górski B
Hered Cancer Clin Pract; 2006 Aug; 4(3):142-52. PubMed ID: 20223018
[TBL] [Abstract][Full Text] [Related]
5. Do founder mutations characteristic of some cancer sites also predispose to pancreatic cancer?
Lener MR; Scott RJ; Kluźniak W; Baszuk P; Cybulski C; Wiechowska-Kozłowska A; Huzarski T; Byrski T; Kładny J; Pietrzak S; Soluch A; Jakubowska A; Lubiński J
Int J Cancer; 2016 Aug; 139(3):601-6. PubMed ID: 27038244
[TBL] [Abstract][Full Text] [Related]
6. Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia.
Sokolenko AP; Rozanov ME; Mitiushkina NV; Sherina NY; Iyevleva AG; Chekmariova EV; Buslov KG; Shilov ES; Togo AV; Bit-Sava EM; Voskresenskiy DA; Chagunava OL; Devilee P; Cornelisse C; Semiglazov VF; Imyanitov EN
Fam Cancer; 2007; 6(3):281-6. PubMed ID: 17333477
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer predisposing alleles in Poland.
Górski B; Cybulski C; Huzarski T; Byrski T; Gronwald J; Jakubowska A; Stawicka M; Gozdecka-Grodecka S; Szwiec M; Urbański K; Mituś J; Marczyk E; Dziuba J; Wandzel P; Surdyka D; Haus O; Janiszewska H; Debniak T; Tołoczko-Grabarek A; Medrek K; Masojć B; Mierzejewski M; Kowalska E; Narod SA; Lubiński J
Breast Cancer Res Treat; 2005 Jul; 92(1):19-24. PubMed ID: 15980987
[TBL] [Abstract][Full Text] [Related]
8. Development of breast tumors in CHEK2, NBN/NBS1 and BLM mutation carriers does not commonly involve somatic inactivation of the wild-type allele.
Suspitsin EN; Yanus GA; Sokolenko AP; Yatsuk OS; Zaitseva OA; Bessonov AA; Ivantsov AO; Heinstein VA; Klimashevskiy VF; Togo AV; Imyanitov EN
Med Oncol; 2014 Feb; 31(2):828. PubMed ID: 24415413
[TBL] [Abstract][Full Text] [Related]
9. Epidemiologic, clinical, and molecular characteristics of hereditary prostate cancer in Latvia.
Abele A; Vjaters E; Irmejs A; Trofimovičs G; Miklaševičs E; Gardovskis J
Medicina (Kaunas); 2011; 47(10):579-85. PubMed ID: 22186123
[TBL] [Abstract][Full Text] [Related]
10. The Prevalence of Founder Mutations among Individuals from Families with Familial Pancreatic Cancer Syndrome.
Lener MR; Kashyap A; Kluźniak W; Cybulski C; Soluch A; Pietrzak S; Huzarski T; Gronwald J; Lubiński J
Cancer Res Treat; 2017 Apr; 49(2):430-436. PubMed ID: 27488870
[TBL] [Abstract][Full Text] [Related]
11. BRCA1 mutations and prostate cancer in Poland.
Cybulski C; Górski B; Gronwald J; Huzarski T; Byrski T; Debniak T; Jakubowska A; Wokołorczyk D; Gliniewicz B; Sikorski A; Stawicka M; Godlewski D; Kwias Z; Antczak A; Krajka K; Lauer W; Sosnowski M; Sikorska-Radek P; Bar K; Klijer R; Romuald Z; Małkiewicz B; Borkowski A; Borkowski T; Szwiec M; Posmyk M; Narod SA; Lubiński J
Eur J Cancer Prev; 2008 Feb; 17(1):62-6. PubMed ID: 18090912
[TBL] [Abstract][Full Text] [Related]
12. High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients.
Suspitsin EN; Sherina NY; Ponomariova DN; Sokolenko AP; Iyevleva AG; Gorodnova TV; Zaitseva OA; Yatsuk OS; Togo AV; Tkachenko NN; Shiyanov GA; Lobeiko OS; Krylova NY; Matsko DE; Maximov SY; Urmancheyeva AF; Porhanova NV; Imyanitov EN
Hered Cancer Clin Pract; 2009 Feb; 7(1):5. PubMed ID: 19338682
[TBL] [Abstract][Full Text] [Related]
13. A common nonsense mutation of the BLM gene and prostate cancer risk and survival.
Antczak A; Kluźniak W; Wokołorczyk D; Kashyap A; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dębniak T; Masojć B; Górski B; Gromowski T; Nagorna A; Gołąb A; Sikorski A; Słojewski M; Gliniewicz B; Borkowski T; Borkowski A; Przybyła J; Sosnowski M; Małkiewicz B; Zdrojowy R; Sikorska-Radek P; Matych J; Wilkosz J; Różański W; Kiś J; Bar K; Domagała P; Stawicka M; Milecki P; Akbari MR; Narod SA; Lubiński J; Cybulski C; ; ; Bryniarski P; Paradysz A; Jersak K; Niemirowicz J; Słupski P; Jarzemski P; Skrzypczyk M; Dobruch J; Domagała W; Chosia M; van de Wetering T; Serrano-Fernández P; Puszyński M; Soczawa M; Switała J; Archimowicz S; Kordowski M; Zyczkowski M; Borówka A; Bagińska J; Krajka K; Szwiec M; Haus O; Janiszewska H; Stembalska A; Sąsiadek MM
Gene; 2013 Dec; 532(2):173-6. PubMed ID: 24096176
[TBL] [Abstract][Full Text] [Related]
14. A novel founder CHEK2 mutation is associated with increased prostate cancer risk.
Cybulski C; Huzarski T; Górski B; Masojć B; Mierzejewski M; Debniak T; Gliniewicz B; Matyjasik J; Złowocka E; Kurzawski G; Sikorski A; Posmyk M; Szwiec M; Czajka R; Narod SA; Lubiński J
Cancer Res; 2004 Apr; 64(8):2677-9. PubMed ID: 15087378
[TBL] [Abstract][Full Text] [Related]
15. Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations.
Sokolenko AP; Bogdanova N; Kluzniak W; Preobrazhenskaya EV; Kuligina ES; Iyevleva AG; Aleksakhina SN; Mitiushkina NV; Gorodnova TV; Bessonov AA; Togo AV; Lubiński J; Cybulski C; Jakubowska A; Dörk T; Imyanitov EN
Breast Cancer Res Treat; 2014 Jun; 145(2):553-62. PubMed ID: 24800916
[TBL] [Abstract][Full Text] [Related]
16. Allelic modification of breast cancer risk in women with an NBN mutation.
Rusak B; Kluźniak W; Wokołorczyk D; Stempa K; Kashyap A; Rudnicka H; Gronwald J; Huzarski T; Dębniak T; Jakubowska A; Szwiec M; Akbari MR; Narod SA; Lubiński J; Cybulski C;
Breast Cancer Res Treat; 2019 Nov; 178(2):427-431. PubMed ID: 31410679
[TBL] [Abstract][Full Text] [Related]
17. NBS1 is a prostate cancer susceptibility gene.
Cybulski C; Górski B; Debniak T; Gliniewicz B; Mierzejewski M; Masojć B; Jakubowska A; Matyjasik J; Złowocka E; Sikorski A; Narod SA; Lubiński J
Cancer Res; 2004 Feb; 64(4):1215-9. PubMed ID: 14973119
[TBL] [Abstract][Full Text] [Related]
18. [The clinical importance of a genetic analysis of moderate-risk cancer susceptibility genes in breast and other cancer patients from the Czech Republic].
Pohlreich P; Kleibl Z; Kleiblová P; Janatová M; Soukupová J; Macháčková E; Házová J; Vašíčková P; Sťahlová Hrabincová E; Navrátilová M; Svoboda M; Foretová L
Klin Onkol; 2012; 25 Suppl():S59-66. PubMed ID: 22920209
[TBL] [Abstract][Full Text] [Related]
19. Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland.
Wokołorczyk D; Kluźniak W; Huzarski T; Gronwald J; Szymiczek A; Rusak B; Stempa K; Gliniewicz K; Kashyap A; Morawska S; Dębniak T; Jakubowska A; Szwiec M; Domagała P; Lubiński J; Narod SA; Akbari MR; Cybulski C;
Int J Cancer; 2020 Nov; 147(10):2793-2800. PubMed ID: 32875559
[TBL] [Abstract][Full Text] [Related]
20. CHEK2 mutations and HNPCC-related colorectal cancer.
Suchy J; Cybulski C; Wokołorczyk D; Oszurek O; Górski B; Debniak T; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dziuba I; Gogacz M; Wiśniowski R; Wandzel P; Banaszkiewicz Z; Kurzawski G; Kładny J; Narod SA; Lubiński J
Int J Cancer; 2010 Jun; 126(12):3005-9. PubMed ID: 19876921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
